Real-world outcomes of advanced melanoma patients not represented in phase III trials.

Rawa Ismail,Michiel C.T. van Zeijl,Liesbeth C. de Wreede,Alfonsus J. M. van den Eertwegh,Anthonius de Boer,Maaike van Dartel,Doranne Hilarius,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Marye J. Boers-Sonderen,Jan Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,D. Piersma,Rozemarijn S. van Rijn,K.P.M. Suijkerbuijk,Albert J. ten Tije,Astrid Aplonia Maria Van Der Veldt,John B. A. G. Haanen,Michel W.J.M. Wouters

Real-world outcomes of advanced melanoma patients not represented in phase III trials.

2020

10042Background: A large proportion of patients with advanced melanoma is not represented in phase III clinical trials, due to ineligibility. Real-world efficacy evidence of immune- and targeted th...

Keywords:

Oncology
real world outcomes
phase iii trials
Physical therapy
Internal medicine
advanced melanoma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations